Literature DB >> 6759266

Virus-induced diabetes mellitus. Glucose abnormalities produced in mice by the six members of the Coxsackie B virus group.

A Toniolo, T Onodera, G Jordan, J W Yoon, A L Notkins.   

Abstract

The capacity of Coxsackie B viruses (CBVs) to produce diabetes in mice was studied before and after passage in various cell types. CBVs that had been passaged in monkey kidney cells or in mouse embryo fibroblasts failed to produce abnormal glucose tolerance tests, whereas virus passaged five or more times in the pancreata of mice or in beta-cell cultures produced transient abnormal glucose tolerance tests. Immunofluorescence and histologic studies revealed that passage of CBVs in cultured beta-cells changed the tropism of these viruses from the acinar pancreas to the islets of Langerhans. Although all six CBV serotypes that had been passaged in beta-cell cultures behaved very similarly, substantial variation was observed with the different virus passages and in some experiments, beta-cell damage and the glucose abnormalities were minimal. From these and other experiments, we conclude that the six members of the CBV group have the potential for infecting and damaging pancreatic beta-cells in mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759266     DOI: 10.2337/diab.31.6.496

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Review series on helminths, immune modulation and the hygiene hypothesis: how might infection modulate the onset of type 1 diabetes?

Authors:  Anne Cooke
Journal:  Immunology       Date:  2009-01       Impact factor: 7.397

2.  Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates.

Authors:  T M Szopa; T Ward; D M Dronfield; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

3.  Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.

Authors:  S Tracy; K M Drescher; N M Chapman; K-S Kim; S D Carson; S Pirruccello; P H Lane; J R Romero; J S Leser
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Virus-induced diabetes: cytomegalovirus and multiple environmental insults.

Authors:  T Onodera; H Suzuki; A Toniolo; A L Notkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

5.  Multi-system coxsackievirus B-6 infection with findings suggestive of diabetes mellitus.

Authors:  G Nigro; M E Pacella; E Patanè; M Midulla
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

6.  Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice.

Authors:  K L Gaines; S G Kayes; G L Wilson
Journal:  Diabetologia       Date:  1986-05       Impact factor: 10.122

7.  Long-term biochemical changes in the islets of Langerhans in mice following infection with encephalomyocarditis virus.

Authors:  L N Hellqvist; C J Rhodes; K W Taylor
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

Review 8.  Diabetes mellitus due to viruses--some recent developments.

Authors:  T M Szopa; P A Titchener; N D Portwood; K W Taylor
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

9.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

10.  Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Authors:  D L Kaufman; M G Erlander; M Clare-Salzler; M A Atkinson; N K Maclaren; A J Tobin
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.